Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:15 AM
Ignite Modification Date:
2025-12-25 @ 1:15 AM
NCT ID:
NCT06126393
Eligibility Criteria:
Inclusion Criteria:
* •Pathologically confirmed as endometrial malignant tumor with complete pathological H＆E stained sections;
* Age ≥ 18 years and ≤ 80 years;
* No other malignant cancers was found;
* The complete immunohistochemical and second-generation sequencing results can be used for the molecular typing of ProMisE;
* Magnetic resonance examination was performed within 2 weeks before treatment, and there was at least one measurable lesion according to RECIST 1.1 Criteria.
Exclusion Criteria:
* • The image quality is poor or the tumor is too small due to serious graphic artifact and degeneration, and the ROI cannot be accurately delineated;
* Patients who received any antitumor therapy before surgery;
* Diagnostic endometrial biopsy before MRI
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT06126393
Study Brief:
Protocol Section:
NCT06126393